Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,401,869
-
Total 13F shares
-
20,149
-
Share change
-
+1,072
-
Total reported value
-
$59,220
-
Price per share
-
$2.92
-
Number of holders
-
8
-
Value change
-
+$2,938
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of MAINZ BIOMED N.V. - Common Stock (MYNZ) as of Q3 2023
As of 30 Sep 2023,
MAINZ BIOMED N.V. - Common Stock (MYNZ) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,149 shares.
The largest 8 holders included
Greenwich Investment Management, Inc., JPMORGAN CHASE & CO, Steward Partners Investment Advisory, LLC, NewEdge Advisors, LLC, CITIGROUP INC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and UBS Group AG.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.